Authors: Nakamura, S Hirano, T Tsujimae, K Aoyama, M Kondo, K Yamamura, Y Mori, T Tominaga, M

Citation: S. Nakamura et al., Antidiuretic effects of a nonpeptide vasopressin V-2-receptor agonist, OPC-51803, administered orally to rats, J PHARM EXP, 295(3), 2000, pp. 1005-1011

Authors: Nakamura, S Yamamura, Y Itoh, S Hirano, T Tsujimae, K Aoyama, M Kondo, K Ogawa, H Shinohara, T Kan, K Tanada, Y Teramoto, S Sumida, T Nakayama, S Sekiguchi, K Kambe, T Tsujimoto, G Mori, T Tominaga, M

Citation: S. Nakamura et al., Characterization of a novel nonpeptide vasopressin V-2-agonist, OPC-51803,in cells transfected human vasopressin receptor subtypes, BR J PHARM, 129(8), 2000, pp. 1700-1706

Authors: Yamamura, Y Nakamura, S Itoh, S Hirano, T Onogawa, T Yamashita, T Yamada, Y Tsujimae, K Aoyama, M Kotosai, K Ogawa, H Yamashita, H Kondo, K Tominaga, M Tsujimoto, G Mori, T

Citation: Y. Yamamura et al., OPC-41061, a highly potent human vasopressin V-2-receptor antagonist: Pharmacological profile and aquaretic effect by single and multiple oral dosingin rats, J PHARM EXP, 287(3), 1998, pp. 860-867